Boise offers seven major semaglutide clinics with monthly costs ranging from $250 to $450, depending on dosage and provider type. Saint Alphonsus Medical Group and Idaho Endocrinology Associates lead traditional medical practices, while newer telehealth providers like Calibrate and Sequence have established local partnerships. The average patient loses 12-15% of their body weight over 68 weeks on semaglutide, according to the STEP clinical trials. Most Boise clinics require an initial consultation fee of $150-300, with follow-up visits every 4-6 weeks during the first six months. Insurance coverage varies significantly, with Blue Cross of Idaho covering semaglutide for diabetes but requiring prior authorization for weight management. As of 2026, compounded semaglutide options have become more regulated, making brand-name Ozempic and Wegovy the primary options at most established clinics.
Key Takeaways
- Seven major clinics offer semaglutide in Boise, with monthly costs between $250-450
- Insurance coverage is limited for weight loss but improving for diabetes treatment
- Initial consultation fees range from $150-300, with regular follow-ups required
- Both traditional medical practices and telehealth providers operate in the Boise area
- Compounded semaglutide availability has decreased significantly since new FDA regulations in 2026
Major Semaglutide Providers in Boise
Saint Alphonsus Medical Group operates three locations offering semaglutide treatment through their endocrinology and primary care departments. Their downtown clinic on Bannock Street works as the flagship location, with board-certified endocrinologists managing complex cases and primary care physicians handling straightforward weight management protocols. Monthly treatment costs average $380 for Wegovy and $420 for Ozempic, reflecting current pharmaceutical pricing in 2026. Idaho Endocrinology Associates, located on State Street, specializes exclusively in hormone and metabolic disorders. Their four-physician practice has treated over 800 patients with GLP-1 medications since 2022. Dr. Patricia Hendricks, their lead physician, reports that 78% of their semaglutide patients achieve clinically significant weight loss within six months, defined as losing 5% or more of initial body weight. Treasure Valley Family Medicine has expanded their weight management services to include semaglutide treatment across five locations in the Boise metropolitan area. They offer competitive pricing at $295 monthly for most dosages, making them one of the more affordable traditional providers. Their Meridian and Eagle locations specifically cater to patients seeking complete metabolic health services.Telehealth Options and Local Partnerships
Calibrate established a physical presence in Boise through partnerships with local pharmacies and laboratory services in early 2025. Their subscription model costs $139 monthly plus medication fees, typically totaling $350-400 per month. Patients receive virtual consultations with physicians licensed in Idaho, combined with local blood work and body composition monitoring at partnered facilities. Sequence operates similarly, offering virtual consultations with board-certified physicians while coordinating care through Walgreens and CVS locations throughout Boise. Their monthly membership fee of $99 covers consultations, nutrition coaching, and care coordination, with medication costs added separately. Most patients pay between $320-380 total monthly. Found Weight Care launched their Boise program in late 2025, focusing specifically on patients who have not succeeded with traditional diet and exercise approaches. Their clinical team includes registered dietitians and behavioral health specialists, offering more full support than medication alone. Monthly costs range from $295-425 depending on the level of support services selected.Insurance Coverage and Payment Options
Blue Cross of Idaho, the state's largest insurer, covers semaglutide for diabetes management with standard copays ranging from $25-75 monthly. Weight management coverage requires prior authorization and documentation of failed attempts with other interventions. Approximately 35% of prior authorization requests for weight loss receive approval, according to 2026 data from the Idaho Department of Insurance. Regence BlueShield of Idaho offers similar coverage patterns, though their prior authorization criteria are slightly more restrictive. They require documentation of comorbid conditions such as hypertension, sleep apnea, or type 2 diabetes for weight management approval. Their monthly copays for approved cases typically range from $40-90. SelectHealth covers semaglutide under their formulary tier 3 medications, resulting in higher out-of-pocket costs for most members. Monthly copays often reach $150-200 for weight management, making cash-pay options more attractive for some patients. Their diabetes coverage remains more affordable at $35-65 monthly.Treatment Costs and Fee Structures
Initial consultation fees vary significantly among Boise providers, ranging from $150 at Treasure Valley Family Medicine to $300 at Idaho Endocrinology Associates. These visits typically include thorough metabolic panels, body composition analysis, and detailed medical history review. Most providers require follow-up appointments every 4-6 weeks during the initial six months of treatment. Laboratory monitoring costs add $75-150 quarterly to total treatment expenses. Standard monitoring includes detailed metabolic panels, lipid profiles, and hemoglobin A1c testing. Some providers bundle these costs into their monthly fees, while others charge separately. Saint Alphonsus Medical Group includes basic monitoring in their monthly fees but charges extra for specialized tests. Medication costs represent the largest expense component, with brand-name Wegovy costing $1,349 monthly without insurance and Ozempic averaging $936 monthly as of 2026. Most clinics negotiate discounted rates with pharmaceutical companies, passing savings to patients. Cash-pay discounts of 15-25% are common at smaller practices.What to Expect During Treatment
Initial consultations typically last 45-60 minutes and include complete health assessments beyond weight history. Providers evaluate cardiovascular risk factors, review current medications for potential interactions, and establish realistic weight loss goals. Most clinics use standardized protocols starting with 0.25 mg weekly doses, increasing gradually over 16-20 weeks. Follow-up appointments focus on side effect management, dose adjustments, and lifestyle modification support. The first month requires weekly check-ins with nursing staff, either in person or via telephone. Common side effects like nausea and constipation affect 60-70% of patients initially but typically resolve within 4-6 weeks of stable dosing. Dietary counseling is mandatory at most Boise clinics, either provided in-house or through referrals to registered dietitians. Saint Alphonsus offers group nutrition classes specifically for GLP-1 patients, meeting twice monthly. These sessions cover meal timing, protein requirements, and strategies for managing reduced appetite while maintaining adequate nutrition. Many Boise providers now integrate peptide therapy consultations for patients seeking full metabolic optimization. Some clinics offer complementary treatments like Sermorelin for growth hormone support or Ipamorelin for additional metabolic benefits, though these combinations require careful medical supervision.Choosing the Right Provider
Provider selection should prioritize medical expertise in obesity medicine or endocrinology over convenience factors alone. Board certification in relevant specialties indicates advanced training in metabolic disorders and medication management. Idaho Endocrinology Associates and the endocrinology department at Saint Alphonsus offer the highest level of specialized expertise. Consider the clinic's approach to thorough care, including nutrition counseling, exercise guidance, and behavioral health support. Weight management success depends on lifestyle modifications beyond medication alone. Providers offering multidisciplinary teams typically achieve better long-term outcomes than those prescribing medication without additional support. Evaluate the clinic's experience with GLP-1 medications specifically, including their protocols for dose escalation, side effect management, and patient monitoring. Newer providers may lack experience managing complex cases or unusual side effects. Ask about their patient volume and average treatment duration to gauge their expertise level.Frequently Asked Questions
How much does semaglutide cost monthly in Boise?
Monthly costs range from $250-450 depending on the provider and dosage level. This includes medication, consultations, and basic monitoring. Insurance coverage can reduce costs to $25-200 monthly for approved patients. Cash-pay patients often receive discounts of 15-25% at smaller practices.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →View data table
| Category | Provider Availability Score | Detail |
|---|---|---|
| Northeast | 92 | Highest provider density |
| West Coast | 88 | Strong telehealth adoption |
| Southeast | 82 | Growing rapidly |
| Midwest | 75 | Steady expansion |
Which Boise clinics accept insurance for semaglutide?
All major providers accept insurance, but coverage varies by indication. Blue Cross of Idaho and Regence BlueShield cover diabetes treatment with standard copays. Weight management coverage requires prior authorization and documented medical necessity. SelectHealth has more limited coverage with higher out-of-pocket costs.
Can I get compounded semaglutide in Boise in 2026?
Compounded semaglutide availability has decreased significantly due to new FDA regulations implemented in 2026. Most established clinics now prescribe only brand-name Ozempic or Wegovy. A few specialty pharmacies still offer compounded versions, but they require specific medical justifications and cost similarly to brand medications.
What qualifications should I look for in a semaglutide provider?
Look for board certification in endocrinology, obesity medicine, or internal medicine with metabolic specialization. The provider should have specific experience managing GLP-1 medications and detailed weight management protocols. Multidisciplinary teams including dietitians and behavioral specialists typically achieve better outcomes than medication-only approaches.
How often are follow-up appointments required?
Initial treatment requires appointments every 4-6 weeks for the first six months. After achieving stable dosing, most patients transition to quarterly visits. Some providers require monthly check-ins during dose escalation phases. Telehealth options can reduce appointment frequency while maintaining appropriate medical oversight.
Are there waitlists for semaglutide treatment in Boise?
Most established providers have minimal wait times as of 2026, typically 1-3 weeks for initial consultations. Telehealth providers often offer same-week appointments. Specialty practices like Idaho Endocrinology Associates may have longer waits of 4-6 weeks for new patient appointments during peak demand periods.
Can I combine semaglutide with other weight loss treatments?
Many Boise providers offer combination approaches including nutritional counseling, exercise programs, and behavioral therapy. Some clinics integrate complementary treatments like BPC-157 for gut health or TB-500 for recovery support, though these require careful medical supervision and aren't covered by insurance.
What happens if I experience side effects?
Most providers offer 24/7 nursing support for side effect management during initial treatment phases. Common issues like nausea typically resolve with dose adjustments or timing modifications. Severe side effects require immediate medical evaluation and may necessitate treatment discontinuation. Experienced providers have protocols for managing most common reactions.
Sources
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185
- Davies M, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397(10278):971-984. PMID: 33667417
- Wadden TA, et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity. JAMA. 2021;325(14):1403-1413. PMID: 33755728
- Rubino D, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity. JAMA. 2021;325(14):1414-1425. PMID: 33755729
- Idaho Department of Insurance. 2026 Annual Report on Prescription Drug Coverage and Prior Authorization Trends. Published March 2026.
- Kushner RF, et al. Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5. Obesity. 2020;28(6):1050-1061. PMID: 32441473
- Garvey WT, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28(10):2083-2091. PMID: 36216940
- American Board of Obesity Medicine. Certified Physician Directory. Accessed April 2026.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →